AMOR-IPAT Research Activities


CAOI Score Survey

In support of the AMOR-IPAT research, we are developing a method of evaluating childbirth outcomes called the "Childbirth Adverse Outcome Index Score" (CAOI Score). The CAOI Score will be based on a list of the potential major adverse outcomes that can occur during pregnancy, labor and childbirth, and will assign a numerical value to each outcome. The higher the value, the more adverse the outcome. Currently, we envision the CAOI Score being based on about 30 adverse childbirth outcomes. This will be a significant improvement over the current AOI Score, which only uses 10 outcomes, many of which are very uncommon.

To help facilitate the development of this new Score, we are soliciting input from as many interested stakeholders as possible, including pregnant women and/or their partners or other family members, health care providers (doctors, nurses, mid-wives, etc.), insurance providers, hospital administrators, etc. To this end, we encourage you to help us in this research effort by completing our brief, online survey.

The survey comprises a list of 29 potentially adverse outcomes that can occur with childbirth during the term period of pregnancy (defined as anytime between 37 weeks 0 days of gestation to 41 weeks 0 days of gestation), divided into Maternal Outcomes (i.e., those pertaining to the mother) and Fetal/Infant Outcomes (i.e., those pertaining to the fetus/infant/newborn child). The purpose of the survey is to help us score each outcome with a number ranging from 1 (=minimal/no adversity) to 1000 (=extreme adversity), which we can then use to develop the CAOI Score.

Please note that all responses to this survey are strictly anonymous. We DO NOT require any usernames or passwords to complete the survey, nor do we collect any personally-identifiable information, such as e-mail or IP addresses.

To open the survey, simply click here or on the "Survey" button, below. Once complete, simply click the "Submit" button to automatically add your anonymous answers to the survey database.



  • NEW! Quasi-meta-analysis of prior AMOR-IPAT studies. An important sub-study for this concept will include the comparison of all pre-39 week, non-indicated labor inductions from the AMOR-IPAT cohorts with the 39 week and beyond deliveries in the usual care group. [Note: Manuscript accepted for publication in the BJOG: An International Journal of Obstetrics and Gynaecology]
  • Retrospective Cohort Studies from Family Medicine maternity care activity at the University of Pennsylvania (1998-2012). Some family physicians used AMOR-IPAT, while others did not. How did the outcomes of their practices vary?
  • Cost-effectiveness study of the HUP-POP Trial.
  • Study of the relationship between yearly labor induction rates and yearly adverse birth outcomes rates (e.g., C/S rates, NICU admission rates, low APGAR score rates) over the past 10-12 years at both tertiary care and secondary care hospitals. As annual labor induction rates rise and fall, we will see what happens to population rates of various birth outcomes.
  • Possible submission to the National Child Health & Human Development (NICHD) of the National Institutes of Health (NIH) for funding for a multi-site R01 RCT proposal involving the use of AMOR-IPAT.

Back to top